MALAT1 and cancer: Several cancer-related studies have revealed that MALAT1 is capable of binding to enhancer of zeste homolog 2 (EZH2), the main catalytic subunit of the histone methyltransferase polycomb repressive complex 2 (PRC2), and promotes oncogenesis by reprograming the chromatin state14–17.